Professor and Chairman of Radiation Oncology, and Adjunct Professor of Internal Medicine/Hematologic Malignancies, University of Oklahoma college of Medicine
Radiation Oncology
Dr. Terence S. Herman, MD
|
|
Give Review
Terence Herman practices Radiation Oncology. He studied medicine at University of Connecticut School of Medicine. University of Connecticut School of Medicine has a rank of 60 in research and a 49 in primary care He received 4 awards: "America's Top Doctors", "Oklahoma Magazine", "America's Top Doctors for Cancer" and "Redbook Magazine: Top Breast Cancer Doctors". Terence Herman is a published doctor. He published 101 publications, including: 'Germ cell nuclear factor is a response element-specific repressor of transcription.' Terence Herman accepts Medicare payments and is listed with Medicare.gov.
Publications
- Serum-circulating miRNAs predict neuroblastoma progression in mouse model of high-risk metastatic Disease.
- RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes.
- Using clinical judgment when pathology and imaging do not correlate: A case for healthy skepticism from the radiation oncologist in the interpretation of surgical path...
- Abscopal effect of low-LET γ-radiation mediated through Rel protein signal transDuction in a mouse model of nontargeted radiation response.
- Dosimetric comparison between IMRT deLivery modes: Step-and-shoot, sliding window, and volumetric modulated arc therapy - for whole pelvis radiation therapy of interme...
- Radiation-induced TNF? cross signaling-dependent nuclear import of NF?B favors metastasis in neuroblastoma.
- Molecular basis of 'hypoxic' breast Cancer cell radio-sensitization: phytochemicals converge on radiation induced Rel signaling.
- EGFR Tyrosine Kinase Inhibitor Pelitinib Regulates Radiation-Induced p65-Dependent Telomerase Activation in Squamous Cell Carcinoma.
- Use of stereotactic body radiation therapy for medically inoperable multiple primary lung Cancer.
- SU-E-T-577: Dosimetric Comparison of Volumetric Modulated Arc Therapy (VMAT), Step and Shoot and Sliding Window IMRT for Prostate Cancer.
- SU-E-T-31: Dosimetric Evaluation of Radiation Therapy Techniques for Early Stage Glottic Squamous Cell Carcinoma (SCC): Three Dimensional Conformal Radiation Therapy (...
- SU-E-J-204: The Dosimetric Impact of Daily Setup Error and Inter-Fraction Prostate Motion on the Calculated Treatment Plan for Patients Receiving IMRT Based Radiation ...
- The dosimetric impact of daily setup error on target volumes and surrounding normal tissue in the treatment of prostate Cancer with intensity-modulated radiation therapy.
- Impact of Curcumin, Raspberry Extract, and Neem Leaf Extract on Rel Protein-Regulated Cell Death/Radiosensitization in Pancreatic Cancer Cells.
- Radiation-triggered TNF{alpha}-NF{kappa}B cross signaling favors survival advantage in human neuroblastoma Cells.
- Curcumin regulates low-linear energy transfer γ-radiation-induced NFκB-dependent telomerase activity in human neuroblastoma Cells.
- Cerebral microvascular rarefaction induced by whole Brain radiation is reversible by systemic hypoxia in mice.
- Stereotactic body radiation therapy (SBRT) and respiratory gating in lung Cancer: dosimetric and radiobiological considerations.
- NFkappaB activity and transcriptional responses in human Breast adenocarcinoma cells after single and fractionated irradiation.
- Nitric oxide-mediated inhibition of NFkappaB regulates hyperthermia-induced apoptosis.
- Curcumin inhibits NFkappaB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma Cells.
- Cell cycle effects and induction of premitotic apoptosis by irofulven in synchronized Cancer cells.
- External beam radiation therapy for hepatoCellular carcinoma: potential of intensity-modulated and image-guided radiation therapy.
- Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate Cancer cells.
- Enhanced topoisomerase II targeting by annamycin and related 4-demethoxy anthracycline Analogues.
- Treatment of Merkel cell carcinoma.
- Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies.
- Repositioning accuracy of a commercially available double-vacuum whole body immobilization System for stereotactic body radiation therapy.
- Radiation treatment of recurrent pheochromocytoma of the Bladder: case report and review of literature.
- Concomitant weekly cisplatin and thoracic radiotherapy for Pancoast tumors of the lung: pilot experience of the San Antonio Cancer Institute.
- Fractionated stereotactic intensity-modulated radiotherapy (FS-IMRT) for small acoustic neuromas.
- Quantitative assessment by measurement and modeling of moBile target elongation in cone-beam computed tomographic imaging.
- Novel Synthetic Monoketone Transmute Radiation-Triggered NFκB-Dependent TNFα Cross-Signaling Feedback Maintained NFκB and Favors Neuroblastoma Regression.
- Anti-pancreatic Cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five differen...
- Germ Cell nuclear factor is a response element-specific repressor of transcription.
- Characterization of a Max:DNA complex by cross-linking to photoactive oligonucleotides.
- Long-term survival in peritoneal mesothelioma. The role of radiotherapy and combined modality treatment.
- Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous Cell carcinoma line and a cis-diamminedichloro...
- Studies on renal aldosterone-binding proteins.
- Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis.
- Cardiac Disease after mediastinal irradiation for seminoma.
- Interaction with hyperthermia of platinum complexes of triaminotriphenylmethane dyes.
- Effect of various oxygenation conditions and fluosol-DA on cytotoxicity and antitumor activity of bleomycin in mice.
- Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.
- Systematic restaging in patients with Hodgkin''s disease: a Southwest Oncology Group Study.
- Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.
- Combination of the minor groove-binder U73-975 or the intercalator mitoxantrone with antitumor alkylating agents in MCF-7 or MCF-7/CP Cells.
- Optimization of perfluorochemical levels with radiation therapy in mice.
- Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
- Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine.
- Phase I clinical trial f mitoxantrone: a new anthracenedione antiCancer drug.
- Effect of step-down heating on the cytotoxicity of adriamycin, bleomycin, and cis-diamminedichloroplatinum.
- Temperature dependence of adriamycin, cis-diamminedichloroplatinum, bleomycin, and 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity in vitro.
- The effect of fluosol-DA and oxygenation status on the activity of cyclophosphamide in vivo.
- Interaction of PtCl4(Fast Black)2 with hyperthermia.
- Tumor resistance to alkylating agents conferred by mechanisms operative only in vivo.
- Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination.
- Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents.
- Fluosol-DA/carbogen with lonidamine or pentoxifylline as modulators of alkylating agents in the FSaIIC fibrosarcoma.
- Systematic re-staging in the management of non-Hodgkin''s lymphomas.
- Collateral sensitivity to methotrexate in Cells resistant to adriamycin.
- Patterns of relapse in patients with small cell carcinoma of the Lung treated with adriamycin-cyclophosphamide chemotherapy and radiation therapy.
- Modulation of alkylating agents by lonidamine in vivo.
- Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary Carcinoma.
- Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.
- Etoposide with lonidamine or pentoxifylline as modulators of alkylating agent activity in vivo.
- 1,2-dithiol-3-thione and dithioester Analogues: potential radioprotectors.
- Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures.
- Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate...
- Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs.
- Regulation of somatic growth by the p160 coactivator p/CIP.
- Combined modality therapy with bleomycin, hyperthermia, and radiation.
- Systematic restaging in non-Hodgkin''s lymphoma: the need to define complete remission.
- Addition of misonidazole, etanidazole, or hyperthermia to treatment with fluosol-DA/carbogen/radiation.
- Interaction with hyperthermia of tetrachloroplatinum(II)(Nile blue)2 and tetrachloroplatinum(II)(neutral red)2 in EMT6 murine Cells and the murine FSaIIC fibrosarcoma.
- Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving Cancer chemotherapy.
- Nabilone: a potent antiemetic cannabinol with minimal euphoria.
- Addition of mitomycin C to cis-diamminedichloroplatinum(II)/hyperthermia/radiation therapy in the FSaIIC fibrosarcoma.
- Acute ischemic vascular events and cisplatin.
- Characteristics of five human tumor Cell lines and sublines resistant to cis-diamminedichloroplatinum(II).
- RTOG quality assurance guidelines for clinical trials using hyperthermia administered by ultrasound.
- RTOG quality assurance guidelines for interstitial hyperthermia.
- Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid Gland.
- Late relapse among patients treated for Hodgkin's Disease.
- DNA interaction, cytotoxicity, and radiosensitization with PtCl4(Nile Blue)2 and PtCl4(Neutral Red)2.
- Interaction of platinum(II) tetrachlorodianion (Fast Black)2 with superhelical DNA and with radiation in vitro and in vivo.
- Interaction of SR-4233 with hyperthermia and radiation in the FSaIIC murine fibrosarcoma tumor System in vitro and in vivo.
- Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia.
- Involvement of the central Nervous system by non-Hodgkin''s lymphoma: the Southwest Oncology Group experience.
- A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.
- Effect of oxygenation, pH and hyperthermia on RSU-1069 in vitro and in vivo with radiation in the FSaIIC murine fibrosarcoma.
- Cytotoxicity, radiosensitization, and DNA interaction of platinum complexes of thiazin and xanthene dyes.
- Platinum complexes of triaminotriphenylmethanes: interaction with DNA and radiosensitization.
- Interaction of D,L- and D-tetraplatin with hyperthermia in vitro and in vivo.
- Summary of studies adding Systemic chemotherapy to local hyperthermia and radiation.
- Multiple modality treatment of carcinoma Cells with Pt(Rh-123)2 plus x-ray plus light.
- Perfluorochemical emulsions: oxygen breathing in radiation sensitization and chemotherapy modulation.
- Addition of 2-nitroimidazole radiosensitizers to cis-diamminedichloroplatinum(II) with radiation and with or without hyperthermia in the murine FSaIIC fibrosarcoma.
- Influence of scheduling on two-drug combinations of alkylating agents in vivo.
- Combination of etanidazole with cyclophosphamide and platinum complexes.
Schools
Univ Of Ct Sch Of Med
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Radiation Oncology
Accepted Insurances
Awards
- America's Top Doctors
- Oklahoma Magazine
- America's Top Doctors for Cancer
- Redbook Magazine: Top Breast Cancer Doctors
Education
-
Stanford University -
University of Arizona -
University of Connecticut School of Medicine
Drug Facts
| NPI NUMBER | 1124097498 | |
| NPPES Provider LastName | HERMAN | |
| NPPES Provider FirstName | TERENCE | |
| NPPES Provider ZIPCode | 731045417 | |
| NPPES Provider State | OK | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 63.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1124097498 |
| Last Name Of The Provider | HERMAN |
| First Name Of The Provider | TERENCE |
| View All |
Similar Doctors
|
|
Dr. Robert C. Gaston, DO
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eugen B. Hug, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lucius S. Doh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ozer Algan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth J. Syzek, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Shripal K. Bhavsar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Foster D. Lasley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zachary P. Nicholas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. J S. Thompson, MD |